F-L319
F-L319 is an ionizable lipid and spleen-targeting mRNA delivery vector. F-L319 can be formulated into lipid nanoparticles (LNPs) to drive spleen-restricted reporter protein expression in mice. F-L319 modulates mRNA encapsulation efficiency, cellular uptake efficiency, and delivery efficiency, with effects varying depending on the composition of LNP formulations. When prepared as pure LNPs, F-L319 shows poor mRNA delivery efficiency in cells; in contrast, hybrid LNPs containing F-L319 and L319 significantly enhance mRNA delivery efficiency in cells.
For research use only. We do not sell to patients.
- Formula: C41H47F32NO6
- Molecular Weight:1257.76
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
When formulated as pure LNPs (100 ng mRNA per well; 12-24 h), F-L319 exhibits poor in vitro mRNA delivery efficiency in DC2.4 and RAW264.7 cells; in contrast, hybrid LNPs containing F-L319 and L319 significantly enhance mRNA delivery efficiency in the aforementioned cell lines, with Hybrid-LNP2 showing the highest potency in DC2.4 cells[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
In Vivo
Hybrid-LNP1 containing 16.7% F-L319 (2 μg mLuc per mouse; i.v.; single dose) shows significantly enhanced in vivo mRNA delivery efficiency with spleen-targeted expression in healthy female C57BL/6 mice[2].
Hybrid-LNP2 containing 25% F-L319 (2 μg mLuc per mouse; i.v.; single dose) shows significantly enhanced in vivo mRNA delivery efficiency with spleen-targeted expression in healthy female C57BL/6 mice, with stronger initial signals than Hybrid-LNP1 that decline more rapidly[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:C57BL/6 (female, 6−8 weeks old)[2]
-
Dosage:2 μg mLuc per mouse
-
Administration:i.v.; single dose
-
Result:Barely exhibited any mRNA expression in vivo, with negligible bioluminescence signals at all tested time points.
Showed nearly no detectable mRNA expression in major organs (spleen, liver, heart, lung, kidney) at 24 h post-injection.\nExhibited significantly higher bioluminescence signals than L319-LNP at 4 h, 12 h, and 24 h post-injection; signals were comparable to Hybrid-LNP2 at all time points.
Showed targeted mRNA expression primarily in the spleen at 24 h post-injection, with much weaker expression in the liver and nearly no expression in other major organs.\nProduced stronger bioluminescence signals than Hybrid-LNP1 at 4 h post-injection, though signals declined more rapidly over time; signals were significantly higher than L319-LNP at all tested time points.
Showed targeted mRNA expression primarily in the spleen at 24 h post-injection, with much weaker expression in the liver and nearly no expression in other major organs.
Chemical Information
-
Molecular Weight 1257.76
-
Formula C41H47F32NO6
-
SMILES
CN(C)CCCC(OC(CCCCCCCC(OCC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)F)=O)CCCCCCCC(OCC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)F)=O)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Western Blot
Western blotting (WB) is a commonly used experimental method in molecular biology, biochemistry, and immunogenetics for identifying and quantifying target proteins. It combines gel electrophoresis with immunoassay, enabling researchers to analyze protein expression, post-translational modifications, and molecular weight.
-
Protocol For Protein Expression And Purification
Recombinant protein expression in Escherichia coli followed by purification of a His-tagged soluble protein by immobilized metal affinity chromatography (IMAC), with optional MBP fusion and TEV tag removal when the construct includes these elements. The biological readout is production of the encoded target protein, detected as an inducible band at the expected molecular mass by SDS-PAGE and quantified by total protein assay or chromatographic absorbance; the purification readout is enrichment of the target protein in elution fractions after selective binding of polyhistidine residues to immobilized Ni2+/metal-chelate resin and elution by imidazole-containing buffer. Expression is driven by an inducible bacterial expression system, commonly T7/lac-based, in which IPTG or lactose/auto-induction activates transcription and translation of the cloned gene; lower induction temperature, lower inducer concentration, induction timing, and solubility-enhancing fusion tags can influence the frac
Purity & Documentation
References
[1]. Vasileva O, et al. Composition of lipid nanoparticles for targeted delivery: application to mRNA therapeutics. Frontiers in pharmacology. 2024;15:1466337. [Content Brief]
[2]. Huo H, et al. A fluorinated ionizable lipid improves the mRNA delivery efficiency of lipid nanoparticles. Journal of materials chemistry. B. 2023 May 17;11(19):4171-4180. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)